Blockchain Registration Transaction Record

Cardio Diagnostics Takes on $393B Heart Disease Crisis with AI

Cardio Diagnostics Holdings (NASDAQ: CDIO) uses AI and epigenetics to detect coronary heart disease from a blood draw, targeting a $393 billion problem. Learn how this innovation could transform cardiovascular care.

This news matters because heart disease is the leading cause of death in the U.S., and current diagnostic methods often miss early signs. Cardio Diagnostics' AI-powered blood test could enable earlier detection and personalized treatment, potentially saving lives and reducing healthcare costs that are projected to soar to $1.4 trillion by 2050. For patients, this means a simpler, more accurate way to assess heart disease risk without invasive procedures.